Scholarlink

<p><i>Hypericum monogynum</i> L. is a plant used in traditional Chinese medicine for treating inflammatory disorders and infectious diseases. Seven new polyprenylated acylphloroglucinols (PPAPs) and seven known PPAPs were isolated from the flowers of <i>H. monogynum</i>. Structurally, compound <b>1</b> features the first rearranged PPAP with a fascinating spirocyclic 5/6/6 ring system, and compound <b>2</b> is the first example of a highly modified PPAP featuring a rare 6/5/5/5-tetracyclic system. Compound <b>7</b> is the first highly degraded PPAP. Their structures were elucidated through comprehensive analysis of HRESIMS, NMR spectroscopy, and electronic circular dichroism calculations. Additionally, five PPAPs exhibited potential multidrug resistance (MDR) reversal activity in MCF-7/ADR cells with reversal fold (RF) values ranging from 9 to 56. Notably, compound <b>3</b>, the strongest MDR modulator, showed a reversal effect (RF = 56) superior to the positive control verapamil (RF = 53) at an equivalent concentration. Furthermore, primary mechanistic investigation indicated that compound <b>10</b> inhibits P-gp transport function without affecting its expression. The potential recognition mechanism between compound <b>10</b> and P-gp was predicted by molecular docking.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Polyprenylated acylphloroglucinols from Hypericum monogynum and their reversal of multidrug resistance in MCF-7/ADR cells

  • 期刊论文

  • 发表日期：

    2026年5月9日

查看全文
  • Yan-Rong Zeng,
  • Peng Zhao,
  • Jing-Yi Yin,
  • Hong-Jin Ban,
  • Zhan Feng,
  • Yu-Xiang Li,
  • Min Yang,
  • Jing Tan,
  • Cheng-Jian Tan,
  • Jue Yang,
  • Xiao-Jiang Hao,
  • Chun-Mao Yuan

摘要

Hypericum monogynum L. is a plant used in traditional Chinese medicine for treating inflammatory disorders and infectious diseases. Seven new polyprenylated acylphloroglucinols (PPAPs) and seven known PPAPs were isolated from the flowers of H. monogynum. Structurally, compound 1 features the first rearranged PPAP with a fascinating spirocyclic 5/6/6 ring system, and compound 2 is the first example of a highly modified PPAP featuring a rare 6/5/5/5-tetracyclic system. Compound 7 is the first highly degraded PPAP. Their structures were elucidated through comprehensive analysis of HRESIMS, NMR spectroscopy, and electronic circular dichroism calculations. Additionally, five PPAPs exhibited potential multidrug resistance (MDR) reversal activity in MCF-7/ADR cells with reversal fold (RF) values ranging from 9 to 56. Notably, compound 3, the strongest MDR modulator, showed a reversal effect (RF = 56) superior to the positive control verapamil (RF = 53) at an equivalent concentration. Furthermore, primary mechanistic investigation indicated that compound 10 inhibits P-gp transport function without affecting its expression. The potential recognition mechanism between compound 10 and P-gp was predicted by molecular docking.